Oramed Pharmaceuticals Inc (ORMP)

2.05
-0.03(-1.44%)
Pre Market
2.08
+0.03(+1.46%)
- Real-time Data
  • Volume:
    1,852,365
  • Day's Range:
    2.04 - 2.17
  • 52 wk Range:
    1.81 - 13.73
Earnings results expected today

Oramed will announce its quarterly financial results today. Traders should take this into account as the share price often fluctuates around this time period.

ORMP Overview

Prev. Close
2.08
Day's Range
2.04-2.17
Revenue
2.92M
Open
2.07
52 wk Range
1.81-13.73
EPS
-1.08
Volume
1,852,365
Market Cap
80.19M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,539,151
P/E Ratio
-1.91
Beta
2.32
1-Year Change
-82.17%
Shares Outstanding
39,114,736
Next Earnings Date
Feb 08, 2023
What is your sentiment on Oramed?
or
Market is currently closed. Voting is open during market hours.

Oramed Pharmaceuticals Inc News

Oramed Pharmaceuticals Inc Analysis

Oramed Pharmaceuticals Inc Company Profile

Oramed Pharmaceuticals Inc Company Profile

Industry
-
Sector
-
Employees
0

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. The company’s product portfolio includes ORMD-0801 Type 2, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes; ORMD-0801, Phase 2 oral insulin capsule for non-alcoholic steatohepatitis, a progressive liver diseases; and ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.

Read More

Analyst Price Target

Average15.16 (+639.51% Upside)
High35.00
Low2.80
Price2.05
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellSellBuyStrong Sell
SummaryStrong SellStrong SellStrong SellNeutralStrong Sell
  • Regret..
    1
    • Great investment. 76% gap down then 10 drop per day. Insiders sold for 13 earlier.
      1
      • god help me how this is not baught like carzy by other companies. they have the future drug. huge change. basically any injection insulin will get their value cut by half in 3-5 years. maybe sooner
        1
        • Today I enter again when opens
          2
          • My feeling is that it increased just too much and too fast riding the euphoria of pharmaceuticals stocks during covid. From 3 to 30 in 1 year (about 1000%) is just too much for every non-speculative stock. I'm sure it will rise again (slowly) together with indexes once will be the time. I'm confident it will reach at least 10$ in 6 months from now.
            0
          • check nvax, srne. All covid plays bursted out
            0
          • I still hold from 13 or something
            0
        • I set my SL in profit @10. FYI
          0
          • moved to 11 today :)
            0
          • I forgot to say triggered and closed at 11 of course
            0
        • Entered again finally at 8.50 premarket
          0
          • it will go up again, my target is 20, where I sold last time
            0
          • The weekly MA200 is at 6.92, it can support the price (it's the half of my entry price).
            0
          • now it's -76% in one day
            0
        • -18% in 3 trading sessions
          0
          • Seems not to take long time, lol
            0
          • 90 cents more and I'm in again.
            0
          • Roberto, what is your favourite book about trading?
            0
        • Oramed's Oravax sub signs pre-purchase agreement for 10 million oral COVID-19 vaccines with Tan Thanh
          0
          • I suspect down to 10
            0
            • https://www.parallax.bio/p/ormp-oramed
              2